ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Reconstructing the immunosenescence core pathway reveals global characteristics in pan-cancer

Zhang, Yakun; Sun, Yue; Gan, Jing; Zhou, Hanxiao; Guo, Shuang; Wang, Xinyue; Zhang, Caiyu; Zheng, Wen; Zhao, Xiaoxi; Zhang, Yunpeng*; Ning, Shangwei*; Li, Xia*哈尔滨医科大学
Cancer Immunology, Immunotherapy2023-11DOI: 10.1007/s00262-023-03521-4
10阅读
引用收藏
分享

摘要

Immunosenescence has been demonstrated to play an important role in tumor progression. However, there is lacking comprehensive analyses of immunosenescence-related pathways. Meanwhile, the sex disparities of immunosenescence in cancer are still poorly understood. In this study, we analyzed the multi-omics data of 12,836 tumor samples, including genomics, transcriptomics, epigenomics, proteomics, and metabolomics. We systematically identified immunosenescence pathways that were disordered across cancer types. The mutations and copy number variations of immunosenescence pathways were found to be more active in pan-cancer. We reconstructed the immunosenescence core pathways (ISC-pathways) to improve the ability of prognostic stratification in 33 cancer types. We also found the head and neck squamous carcinoma (HNSC) contained abundant sex-specific immunosenescence features and showed sex differences in survival. We found that OSI-027 was a potential sex-specific drug in HNSC tumors, which tended to be more effective in male HNSC by targeting the MTOR gene in the PI3K-Akt signaling pathway. In conclusion, our study provided a systematic understanding of immunosenescence pathways and revealed the global characteristics of immunosenescence in pan-cancer. We highlighted MTOR gene could be a powerful immunosenescence biomarker of HNSC that helps to develop sex-specific immunosenescence drugs.

学科与关键词

关键词
ImmunosenescencePathwayPan-cancerSex differenceMulti-omics analysis
相关
加载中…
  • Pan-cancer transcriptomic analysis identified six classes of immunosenescence genes revealed molecular links between aging, immune system and cancer
    Wang, Xinyue; Guo, Shuang; Zhou, Hanxiao; Sun, Yue; Gan, Jing; Zhang, Yakun; Zheng, Wen; Zhang, Caiyu; Wang, Peng; Zhi, Hui; Gao, Yue; Chen, Xiaofeng*; Ning, Shangwei*GENES AND IMMUNITY, 2023, 24(2): 81-91.被引 2
  • Immune Pathways with Aging Characteristics Improve Immunotherapy Benefits and Drug Prediction in Human Cancer
    Wang, Xinyue; Guo, Shuang; Zhou, Hanxiao; Sun, Yue; Gan, Jing; Zhang, Yakun; Zheng, Wen; Zhang, Caiyu; Zhao, Xiaoxi; Xiao, Jiebin; Wang, Li; Gao, Yue*; Ning, Shangwei*Cancers, 2023, 15(2): 342.被引 1
  • An Immunosenescence-Related Gene Signature to Evaluate the Prognosis, Immunotherapeutic Response, and Cisplatin Sensitivity of Bladder Cancer
    Zhou, Ranran; Liang, Jingjing; Tian, Hu; Chen, Qi; Yang, Cheng; Liu, Cundong*DISEASE MARKERS, 2022, 2022: 2143892.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancer Immunology, Immunotherapy
发表日期
2023-11
卷期
第 72 卷, 第 11 期
页码
3693-3705
DOI
10.1007/s00262-023-03521-4
语言
ENGLISH
成果收录
SCIE

作者

  • Z

    Zhang, Yakun (第一作者)

    harbin med univ

  • S

    Sun, Yue

    harbin med univ

查看全部 12 位作者收起作者
  • G

    Gan, Jing

    harbin med univ

  • Z

    Zhou, Hanxiao

    harbin med univ

  • G

    Guo, Shuang

    harbin med univ

  • W

    Wang, Xinyue

    harbin med univ

  • Z

    Zhang, Caiyu

    harbin med univ

  • Z

    Zheng, Wen

    harbin med univ

  • Z

    Zhao, Xiaoxi

    harbin med univ

  • Z

    Zhang, Yunpeng (通讯)

    harbin med univ

  • N

    Ning, Shangwei (通讯)

    harbin med univ

  • L

    Li, Xia (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417